Skip to main navigation Skip to search Skip to main content

RUBELLA VIRAEMIA AND ANTIBODY RESPONSES AFTER RUBELLA VACCINATION AND REIMMUNISATION

  • Henry H. Balfour
  • , Karl E. Groth
  • , Charlene K. Edelman
  • , Don P. Amren
  • , Jennifer M. Best
  • , J. E. Banatvala

Research output: Contribution to journalArticlepeer-review

Abstract

Eleven 4-13 year old schoolgirls, who were seronegative by haemagglutination inhibition (HI) and radioimmunoassay (RIA) tests despite having been given HPV77-DE5 vaccine 3-9 years previously, were revaccinated with RA27/3. They showed evidence of residual immunity since they had accelerated immune responses, little or no rubella-specific IgM, no viraemia, and no vaccine-induced reactions. In contrast, all but one of the five adult women who were primary vaccinees showed a more delayed immune response. Three of four women tested had viraemia and two had vaccine-induced reactions. Enhanced HI and enhanced RIA showed that many of the schoolgirls had antibody before challenge, as did a fifth adult, who also showed an accelerated immune response, yet became viraemic.

Original languageEnglish (US)
Pages (from-to)1078-1080
Number of pages3
JournalThe Lancet
Volume317
Issue number8229
DOIs
StatePublished - May 16 1981

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'RUBELLA VIRAEMIA AND ANTIBODY RESPONSES AFTER RUBELLA VACCINATION AND REIMMUNISATION'. Together they form a unique fingerprint.

Cite this